Publication | Closed Access

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

Chronic PhaseHematological MalignancyImmunologyHematologyMyeloid NeoplasiaChronic Myelogenous LeukemiaRadiation OncologyMedicineCell BiologyCancer ResearchHealth Sciences